Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling
- 132 Downloads
The aim of this study was to investigate the effects of creatine supplementation on muscle wasting in Walker-256 tumor-bearing rats.
Wistar rats were randomly assigned into three groups (n = 10/group): control (C), tumor bearing (T), and tumor bearing supplemented with creatine (TCr). Creatine was provided in drinking water for a total of 21 days. After 11 days of supplementation, tumor cells were implanted subcutaneously into T and TCr groups. The animals’ weight, food and water intake were evaluated along the experimental protocol. After 10 days of tumor implantation (21 total), animals were euthanized for inflammatory state and skeletal muscle cross-sectional area measurements. Skeletal muscle components of ubiquitin–proteasome pathways were also evaluated using real-time PCR and immunoblotting.
The results showed that creatine supplementation protected tumor-bearing rats against body weight loss and skeletal muscle atrophy. Creatine intake promoted lower levels of plasma TNF-α and IL-6 and smaller spleen morphology changes such as reduced size of white pulp and lymphoid follicle compared to tumor-bearing rats. In addition, creatine prevented increased levels of skeletal muscle Atrogin-1 and MuRF-1, key regulators of muscle atrophy.
Creatine supplementation prevents skeletal muscle atrophy by attenuating tumor-induced pro-inflammatory environment, a condition that minimizes Atrogin-1 and MuRF-1-dependent proteolysis.
KeywordsMuscle loss Proteolysis Oxidative stress Cachexia Cancer
Supported by CAPES-Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil #88881.068035/2014-01.
Compliance with ethical standards
Conflict of interest
All authors declared that there is no potential conflict of interests regarding this article.
- 7.Powers SK, Morton AB, Ahn B, Smuder AJ (2016) Redox control of skeletal muscle atrophy. Free Radic Biol Med 98:208–217. https://doi.org/10.1016/j.freeradbiomed.2016.02.021 CrossRefGoogle Scholar
- 17.Tarnopolsky MA, Mahoney DJ, Vajsar J et al (2004) Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62:1771–1777. https://doi.org/10.1212/01.WNL.0000125178.18862.9D CrossRefGoogle Scholar
- 26.Padilha CS, Borges FH, Costa Mendes da Silva LE et al (2017) Resistance exercise attenuates skeletal muscle oxidative stress, systemic pro-inflammatory state, and cachexia in Walker-256 tumor-bearing rats. Appl Physiol Nutr Metab 42:916–923. https://doi.org/10.1139/apnm-2016-0436 CrossRefGoogle Scholar
- 40.Khanna NK, Madan BR (1978) Studies on the anti-inflammatory activity of creatine. Arch Int Pharmacodyn Thérapie 231:340–350Google Scholar
- 42.Barbieri E, Guescini M, Calcabrini C et al (2016) Creatine prevents the structural and functional damage to mitochondria in myogenic, oxidatively stressed C2C12 cells and restores their differentiation capacity. Oxid Med Cell Longev 5152029:1–12. https://doi.org/10.1155/2016/5152029 CrossRefGoogle Scholar